Immune conversion of cancer cells sensitizes them to immunotherapy
November 14, 2022 -- Researchers at the University of Texas MD Anderson Cancer Center have developed a nanotechnology platform that changes the immune system's perception of solid tumor cells, making them more receptive to immunotherapy. Their study, published November 10 in the journal Nature Nanotechnology, details the platform's use in artificially attaching activation molecules to [...]